Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BeiGene Appoints New President | Contract Pharma
Breaking News, Promotions & Moves

BeiGene Appoints New President

Dr. Xiaobin Wu has more than 25 years of experience in the pharmaceutical industry

BeiGene has appointed Dr. Xiaobin Wu to the position of general manager of China and president of the company.

 

Dr. Wu has more than 25 years of experience in the pharmaceutical industry including 17 years leading China operations of multinational companies, with expertise in integrated research and development, strategy, commercialization, and general management. He joins BeiGene from Pfizer China, where he served as Country Manager since 2009 and was the Regional President of Pfizer Essential Health for Greater China. 

 

Dr. Wu also currently serves as a Vice Chairman of the China R&D-based Pharmaceutical Industry Association Committee (RDPAC).

 

“Dr. Wu has a track record of repeatedly building and operating successful organizations in China.  His strong leadership has allowed him to build exceptional teams, launch impactful patient therapies, and drive outstanding results for these organizations; all of which will be critical to helping BeiGene reach the next stage in its growth,” said John Oyler, founder, chief executive officer and chairman of BeiGene.

 

“I am impressed by BeiGene’s entrepreneurial spirit, the quality of its science and its employees, and its drive to become a global leader in the discovery, development and commercialization of innovative medicines,” Dr. Wu commented. “The future of BeiGene is bright, and I am excited to be a part of this truly unique company.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters